Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 12 02 2021
revised: 06 07 2021
accepted: 08 07 2021
pubmed: 28 8 2021
medline: 5 3 2022
entrez: 27 8 2021
Statut: ppublish

Résumé

In DSM-5, definitions of substance use disorders (SUD) were changed considerably from DSM-IV, yet little is known about how well DSM-IV and DSM-5 SUD diagnoses agree among substance users. Because data from many studies are based on DSM-IV diagnostic criteria, understanding the agreement between DSM-5 and DSM-IV SUD diagnoses and reasons for discordance between these diagnoses is crucial for comparing results across studies. Prevalences and chance-corrected agreement of DSM-5 SUD and DSM-IV substance dependence were evaluated in 588 substance users in a suburban inpatient addiction program and an urban medical center, using a semi-structured interview (PRISM-5). Alcohol, tobacco, cannabis, cocaine, heroin, opioid, sedative, and stimulant use disorders were examined. Cohen's kappa was used to assess agreement between DSM-5 and DSM-IV SUD (abuse or dependence), DSM-5 SUD and DSM-IV dependence, and DSM-5 moderate/severe SUD and DSM-IV dependence. Agreement between DSM-5 and DSM-IV SUD was excellent for all substances (κ = 0.84-0.99), except for cannabis and tobacco (κ = 0.75; 0.80, respectively). The most common reason for diagnostic discrepancies was a positive DSM-5 SUD diagnosis but no DSM-IV diagnosis, due to the lowered DSM-5 SUD threshold. Agreement between DSM-5 SUD and DSM-IV dependence was excellent for all substances (κ = 0.88-0.94), except for alcohol, tobacco, and cannabis (κ = 0.63-0.75). Agreement between moderate/severe DSM-5 SUD and DSM-IV dependence was excellent across all substances. While care should be used in interpreting results of studies using different methods, studies relying on DSM-IV or DSM-5 SUD diagnostic criteria offer similar information and thus can be compared when accumulating a body of evidence.

Sections du résumé

BACKGROUND
In DSM-5, definitions of substance use disorders (SUD) were changed considerably from DSM-IV, yet little is known about how well DSM-IV and DSM-5 SUD diagnoses agree among substance users. Because data from many studies are based on DSM-IV diagnostic criteria, understanding the agreement between DSM-5 and DSM-IV SUD diagnoses and reasons for discordance between these diagnoses is crucial for comparing results across studies.
MEASUREMENTS
Prevalences and chance-corrected agreement of DSM-5 SUD and DSM-IV substance dependence were evaluated in 588 substance users in a suburban inpatient addiction program and an urban medical center, using a semi-structured interview (PRISM-5). Alcohol, tobacco, cannabis, cocaine, heroin, opioid, sedative, and stimulant use disorders were examined. Cohen's kappa was used to assess agreement between DSM-5 and DSM-IV SUD (abuse or dependence), DSM-5 SUD and DSM-IV dependence, and DSM-5 moderate/severe SUD and DSM-IV dependence.
RESULTS
Agreement between DSM-5 and DSM-IV SUD was excellent for all substances (κ = 0.84-0.99), except for cannabis and tobacco (κ = 0.75; 0.80, respectively). The most common reason for diagnostic discrepancies was a positive DSM-5 SUD diagnosis but no DSM-IV diagnosis, due to the lowered DSM-5 SUD threshold. Agreement between DSM-5 SUD and DSM-IV dependence was excellent for all substances (κ = 0.88-0.94), except for alcohol, tobacco, and cannabis (κ = 0.63-0.75). Agreement between moderate/severe DSM-5 SUD and DSM-IV dependence was excellent across all substances.
CONCLUSION
While care should be used in interpreting results of studies using different methods, studies relying on DSM-IV or DSM-5 SUD diagnostic criteria offer similar information and thus can be compared when accumulating a body of evidence.

Identifiants

pubmed: 34450471
pii: S0376-8716(21)00453-1
doi: 10.1016/j.drugalcdep.2021.108958
pmc: PMC8977110
mid: NIHMS1786878
pii:
doi:

Substances chimiques

Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

108958

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA018652
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA031099
Pays : United States

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Drug Alcohol Depend. 2019 Dec 1;205:107621
pubmed: 31698323
JAMA. 2013 Apr 24;309(16):1691-2
pubmed: 23440257
Drug Alcohol Depend. 2009 Mar 1;100(3):221-7
pubmed: 19062204
Am J Psychiatry. 1999 Jun;156(6):897-901
pubmed: 10360129
Drug Alcohol Depend. 1999 Feb 1;53(3):215-22
pubmed: 10080047
Int J Offender Ther Comp Criminol. 2014 Jun;58(6):638-54
pubmed: 23596278
Drug Alcohol Depend. 2011 Nov 1;118(2-3):202-8
pubmed: 21514750
Drug Alcohol Rev. 2010 Nov;29(6):631-40
pubmed: 20973848
Addiction. 2006 Sep;101 Suppl 1:59-75
pubmed: 16930162
JAMA Psychiatry. 2016 Jan;73(1):39-47
pubmed: 26580136
Addict Behav. 2015 Feb;41:46-50
pubmed: 25305657
Public Health Rev. 2014;35(2):
pubmed: 28366975
Drug Alcohol Depend. 2008 Jul 1;96(1-2):187-91
pubmed: 18430524
Drug Alcohol Depend. 1997 Sep 25;47(3):217-26
pubmed: 9306047
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Subst Abus. 2007;28(3):7-30
pubmed: 18077300
Drug Alcohol Depend. 1998 Mar 1;50(1):19-26
pubmed: 9589269
Am J Psychiatry. 2013 Aug;170(8):834-51
pubmed: 23903334
Addiction. 2011 May;106(5):941-50
pubmed: 21205055
Alcohol Clin Exp Res. 2020 Oct;44(10):2084-2096
pubmed: 32772383
Drug Alcohol Depend. 2012 Apr 1;122(1-2):28-37
pubmed: 21963333
Nat Neurosci. 2018 Dec;21(12):1656-1669
pubmed: 30482948
Drug Alcohol Depend. 2013 Jan 1;127(1-3):215-9
pubmed: 22884164
Drug Alcohol Depend. 2012 Apr 1;122(1-2):38-46
pubmed: 21963414
Drug Alcohol Depend. 2014 Jul 1;140:213-6
pubmed: 24793367
Biol Psychiatry. 2004 Nov 15;56(10):703-13
pubmed: 15556110
Bull World Health Organ. 1981;59(2):225-42
pubmed: 6972816
Addiction. 2011 Nov;106(11):1935-43
pubmed: 21631621
Addict Behav. 2012 Jun;37(6):722-8
pubmed: 22386237
J Gen Intern Med. 2019 Dec 10;:
pubmed: 31432438
J Stud Alcohol Drugs. 2019 May;80(3):319-330
pubmed: 31250797
Lancet Psychiatry. 2018 Dec;5(12):987-1012
pubmed: 30392731
Front Psychol. 2015 Aug 04;6:1108
pubmed: 26300808
JAMA. 2020 Jun 9;323(22):2310-2328
pubmed: 32515820
Drug Alcohol Depend. 2020 Nov 1;216:108294
pubmed: 33007702
JAMA. 2018 Aug 28;320(8):815-824
pubmed: 30167705
Br Med J. 1976 May 1;1(6017):1058-61
pubmed: 773501
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Drug Alcohol Depend. 2010 Sep 1;111(1-2):146-54
pubmed: 20537809
J Stud Alcohol Drugs. 2017 May;78(3):442-451
pubmed: 28499112
Drug Alcohol Depend. 2019 Nov 1;204:107468
pubmed: 31586809
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070

Auteurs

Ofir Livne (O)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States.

Dvora Shmulewitz (D)

New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, United States.

Malka Stohl (M)

New York State Psychiatric Institute, New York, NY, United States.

Zachary Mannes (Z)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States.

Efrat Aharonovich (E)

New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, United States.

Deborah Hasin (D)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States; New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, United States. Electronic address: deborah.hasin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH